Kenya...Gavi, the Global Alliance for Vaccines and Immunisations and...GlaxoSmithKline (GSK)...[launched] its vaccine against pneumococcal disease. There is every likelihood that the vaccine will save thousands of childrens' lives in Kenya...Gavi now hopes to roll out a pneumococcal immunisation programme in every eligible developing country…To persuade the big research and development pharma companies to manufacture a vaccine suitable for Africa…they were promised sales [financed by governments and foundations]...Deals were signed with GSK and with Pfizer, who will each provide 600,000 doses of vaccines they have developed specifically for the poorest countries…[T]he Pfizer vaccine will be introduced in other African countries. [also refers to Serum Institute of India]